Skip to content

Thermo Fisher Scientific TMO Total Liabilities & Equity

Total Liabilities & Equity at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$50.83B-6.7%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$9.79B+2.8%
GLW
CorningGLW
$32.96B+14.6%
Revvity logo
RevvityRVTY
$12B-2.9%
Kewaunee Scientific Corporation logo
Kewaunee Scientific CorporationKEQU
$178.31M-8.4%
Danaher logo
DanaherDHR
$92.37B+13.2%

Other financials

Income statement

See full
Revenue$12.0B
Operating income$2.1B
Net income$1.7B+7.4%
EPS (diluted)$4.68+9.3%

Balance sheet

See full
Cash & equivalents$4.1B-11.7%
Total debt$39.2B+4.6%
Total equity$52.7B+4.3%
Total assets$113.17B+11.8%

Cash flow

See full
Operating cash flow$2.1B+51.9%
CapEx-$1.2B-509%
Free cash flow$923.0M-16.5%

Valuation

See full
Market cap$214.21B+17.7%
Enterprise value$249.32B+16.0%
P/E30.8×+3.1×
P/S4.8×-0.9×

Profitability

See full
Gross margin58.3%
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%+0.1pp
Debt / equity0.7×0.0×
Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The official record: Thermo Fisher Scientific’s 8-K, filed July 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Thermo Fisher Scientific's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Thermo Fisher Scientific's total liabilities & equity?
Thermo Fisher Scientific (TMO) reported total liabilities & equity of $113.17B in Q2 2026.
How has Thermo Fisher Scientific's total liabilities & equity changed year-over-year?
Thermo Fisher Scientific's total liabilities & equity increased by 11.8% year-over-year, from $101.23B to $113.17B.
What is the long-term trend for Thermo Fisher Scientific's total liabilities & equity?
Over 5 years (2020 to 2025), Thermo Fisher Scientific's total liabilities & equity has grown at a 9.8% compound annual growth rate (CAGR), from $69.05B to $110.34B.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.